Surgery and Chemotherapy for Gastrointestinal Lymphomas
Author Information
Author(s): G. Bellesi, R. Alterini, A. Messori, A. Bosi, F. Bernardi, S. di Lollol, P. Rossi Ferrini
Primary Institution: Universita degli Studi e Ospedale di Careggi, Firenze, Italy
Hypothesis
Does chemotherapy following surgical resection improve outcomes in patients with primary gastrointestinal non-Hodgkin's lymphomas?
Conclusion
Chemotherapy after surgery leads to long-term remission in patients with primary gastrointestinal lymphomas.
Supporting Evidence
- 81% of patients achieved complete remission after chemotherapy.
- 76% cause-specific survival rate at 10 years for treated patients.
- Survival was significantly influenced by the type of surgical resection and disease stage.
Takeaway
Doctors found that giving chemotherapy after surgery helps many patients with stomach and intestine cancers feel better for a long time.
Methodology
The study analyzed 55 patients with primary gastrointestinal non-Hodgkin's lymphoma who underwent surgery followed by chemotherapy.
Potential Biases
Potential bias due to the single-center design and lack of randomization.
Limitations
The study was conducted at a single center and may not be generalizable to all populations.
Participant Demographics
Median age was 55 years, with a range from 10 to 79 years; 53% male and 47% female.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website